Literature DB >> 21280982

Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation.

Jochen Winter1, Annette Pantelis, Rudolf Reich, Markus Martini, Dominik Kraus, Soeren Jepsen, Jean-Pierre Allam, Natalija Novak, Matthias Wenghoefer.   

Abstract

The objective of this study was to investigate the impact of human beta-defensins (hBDs) on oral squamous cell carcinoma (OSCC) proliferation and hBD expression in vitro. BHY-OSCC cell lines were stimulated with hBD-1, -2, and -3. Proliferation of BHY cells was ascertained and hBD-mRNA expression was evaluated by real-time PCR. Proliferation of BHY cells decreased by 25% in response to hBD-1 stimulation but increased after stimulation with hBD-2 and -3. HBD-1 stimulation enhanced hBD-3 expression, whereas HBD-2 stimulation decreased early hBD-3 expression. HBD-3 stimulation enhanced hBD-1 expression. HBDs profoundly impact on OSCC proliferation and hBD expression in vitro. Therefore, hBD-1 might function as a tumor suppressor gene in OSCCs, while hBD-2 and -3 might be protooncogenes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280982     DOI: 10.3109/07357907.2010.543210

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  18 in total

1.  Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins.

Authors:  T Hoppe; D Kraus; N Novak; R Probstmeier; M Frentzen; M Wenghoefer; S Jepsen; J Winter
Journal:  Tumour Biol       Date:  2016-08-01

Review 2.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

3.  Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.

Authors:  Jochen Winter; Dominik Kraus; Jan Reckenbeil; Rainer Probstmeier
Journal:  Tumour Biol       Date:  2015-12-28

4.  EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis.

Authors:  Wen-Juan Liu; Xiu-Jun Liu; Jian Xu; Liang Li; Yi Li; Sheng-Hua Zhang; Jia-Lin Wang; Qing-Fang Miao; Yong-Su Zhen
Journal:  Acta Pharmacol Sin       Date:  2018-07-16       Impact factor: 6.150

Review 5.  Alarmins and immunity.

Authors:  Zhen Han; Joost J Oppenheim
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

6.  Cigarette smoke extract induces differential expression levels of beta-defensin peptides in human alveolar epithelial cells.

Authors:  Tony Pierson; Sarah Learmonth-Pierson; Daniel Pinto; Monique L van Hoek
Journal:  Tob Induc Dis       Date:  2013-04-29       Impact factor: 2.600

7.  Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.

Authors:  Jochen Winter; Annette Pantelis; Dominik Kraus; Jan Reckenbeil; Rudolf Reich; Soeren Jepsen; Hans-Peter Fischer; Jean-Pierre Allam; Natalija Novak; Matthias Wenghoefer
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

8.  Expression and new exon mutations of the human Beta defensins and their association on colon cancer development.

Authors:  Abdelhabib Semlali; Abdullah Al Amri; Arezki Azzi; Omair Al Shahrani; Maha Arafah; Muhammad Kohailan; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Nahla Ali Azzam; Narasimha Reddy Parine; Mahmoud Rouabhia; Mohammad S Alanazi
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

9.  Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients.

Authors:  Qi Han; Ruinan Wang; Chongkui Sun; Xin Jin; Dongjuan Liu; Xin Zhao; Lili Wang; Ning Ji; Jing Li; Yu Zhou; Ling Ye; Xinhua Liang; Lu Jiang; Ga Liao; Hongxia Dan; Xin Zeng; Qianming Chen
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  HBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion.

Authors:  Yoshitaka Kamino; Yoshihito Kurashige; Osamu Uehara; Jun Sato; Michiko Nishimura; Koki Yoshida; Toshiya Arakawa; Hiroki Nagayasu; Masato Saitoh; Yoshihiro Abiko
Journal:  Oncol Rep       Date:  2014-06-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.